SYK
Stryker Corporation · NYSE
- Sector Health Technology
- Industry Medical Specialties
- Website ryker.com
- Employees(FY) 51000
- ISIN US8636671013
Performance
-3.77%
1W
-1.0%
1M
+2.6%
3M
+8.77%
6M
+26.1%
YTD
+28.55%
1Y
Profile
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Technical Analysis of SYK 2024-12-12
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-12 12:28
- 2024-12-12 11:30
- 2024-12-12 10:46
Needham Adjusts Stryker Price Target to $442 From $409(MT Newswires)
- 2024-12-12 08:24
- 2024-12-12 07:42
- 2024-12-11 10:36
- 2024-12-11 10:36
- 2024-12-11 07:26
- 2024-12-10 08:00
Stryker declares an $0.84 per share quarterly dividend(GlobeNewswire)
- 2024-12-09 19:00
Stryker declares an $0.84 per share quarterly dividend(Globenewswire)
- 2024-12-06 11:31
- 2024-12-05 11:45
- 2024-12-04 05:00
- 2024-12-03 16:27
- 2024-12-03 14:04
Stryker Corporation (SYK): A Bull Case Theory(Insider Monkey)
- 2024-12-03 09:42
- 2024-12-02 14:29
- 2024-12-02 08:27
- 2024-11-27 11:40
- 2024-11-27 11:12
- 2024-11-20 20:15
- 2024-11-20 09:29
- 2024-11-20 03:21
Stryker Bringing in Big Money(FX Empire)
- 2024-11-19 20:05
- 2024-11-19 09:05
- 2024-11-15 08:00
- 2024-11-14 20:05
- 2024-11-14 09:05
- 2024-11-12 20:22
Analyst Report: Stryker Corporation(Morningstar Research)
- 2024-11-11 11:40
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.